Stay informed on ABBV stock with the most important news summaries, insider trading, valuation highlights and analyst recommendations

ABBV stock news: A summarized overview for you, just the bottom line of the most recent news items!

Last Updated: February 23, 2024

Real-time price chart of ABBV stock

Stay up-to-date with the latest performance of AbbVie, (ABBV) through our real-time stock chart, providing live insights into its market movements

ABBV stock valuation - less noise, just the highlights

  • With a P/S ratio of 5.75, ABBV may be considered undervalued compared to its sales performance over the past 5 years, presenting a potential buying opportunity for investors.
  • The PEG ratio of 19.83 suggests the stock may be overvalued when considering its growth prospects relative to its current price.
  • ABBV has a high forward P/E ratio of 14.48, indicating potential overvaluation based on future earnings expectations.

Stay informed with the latest ABBV stock analyst recommendations:

  • On Jan 29, 2024, William Blair upgraded ABBV from Market Perform to Outperform, indicating a positive shift in their outlook for the stock.
  • In October 2023, Barclays upgraded ABBV from Equal Weight to Overweight, with an increased price target from $160 to $170, suggesting confidence in the stock's potential for growth.
  • ABBV has seen a mix of upgrades and downgrades from various analysts, indicating varying opinions on the stock but overall, the recent changes have shown more positive shifts in recommendations, such as upgrades from Goldman and William Blair.

Stay updated on ABBV stock insider trading with these key points:

  • Richard A. Gonzalez, the Chairman of the Board and CEO, has been involved in significant sales of ABBV stock, with the most recent sale on August 1st totaling 60,000 shares valued at over $8.9 million. This may indicate a lack of confidence in the stock's performance or future outlook.
  • Elaine K. Sorg, the SVP of US Commercial Operations, has been exercising stock options and selling shares consistently in 2022, with the most recent sale on April 25th totaling over $1 million. Investors may want to pay attention to her trading activity as she plays a key role in the company's commercial operations.
  • Jeffrey Ryan Stewart, the EVP and Chief Commercial Officer, also exercised stock options and sold a significant number of shares in March 2022, totaling over $8 million. This could be seen as a signal of profit-taking or a lack of bullish sentiment from an insider perspective.

ABBV technical analysis

Unlock insights to make smarter investment decisions with this real-time technical analysis tool. Dive in to see the latest buy and sell signals tailored for today's dynamic market. Get the market's inside scoop in a flash! Peek at our fun and user-friendly ratings to see what it is whispering about your ABBV stock, within various timeframes.

Join the Discussion: What's your outlook on ABBV stock's performance?

Are you considering investing in ABBV or have you already done so? Share your thoughts below with the investor and trader community at, share your angles, analysis, predictions, or questions about ABBV in the comments below! Your input matters to us.

Explore additional stocks:

Discover Airbnb stock with its new summaries, insider trading, valuation highlights and analyst recommendations